JP7142813B2 - アミコラトプシス・ルリダ由来シトクロムp450を用いた分岐状脂肪族または芳香族基質のヒドロキシ化法 - Google Patents

アミコラトプシス・ルリダ由来シトクロムp450を用いた分岐状脂肪族または芳香族基質のヒドロキシ化法 Download PDF

Info

Publication number
JP7142813B2
JP7142813B2 JP2019547195A JP2019547195A JP7142813B2 JP 7142813 B2 JP7142813 B2 JP 7142813B2 JP 2019547195 A JP2019547195 A JP 2019547195A JP 2019547195 A JP2019547195 A JP 2019547195A JP 7142813 B2 JP7142813 B2 JP 7142813B2
Authority
JP
Japan
Prior art keywords
enzyme
cytochrome
ferredoxin
aluc09
hydroxylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019547195A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019536479A (ja
JP2019536479A5 (enExample
Inventor
チャールズ ポール スチール,ジョナサン
リソ,アントニオ デ
セント エドワード ウィリアムズ,ヘッドリー
ケリー フィップス,リチャード
キース リグリー,スティーブン
リンダ ニャチコ,キンガ
プーン,ビンセント
シュルツ,セバスチャン
マキシム ワード,ジョン
Original Assignee
ハイファ ディスカバリー リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ハイファ ディスカバリー リミテッド filed Critical ハイファ ディスカバリー リミテッド
Publication of JP2019536479A publication Critical patent/JP2019536479A/ja
Publication of JP2019536479A5 publication Critical patent/JP2019536479A5/ja
Application granted granted Critical
Publication of JP7142813B2 publication Critical patent/JP7142813B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/165Heterorings having nitrogen atoms as the only ring heteroatoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/167Heterorings having sulfur atoms as ring heteroatoms, e.g. vitamin B1, thiamine nucleus and open chain analogs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • C12P7/42Hydroxy-carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/66Preparation of oxygen-containing organic compounds containing the quinoid structure

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
JP2019547195A 2016-11-15 2017-11-15 アミコラトプシス・ルリダ由来シトクロムp450を用いた分岐状脂肪族または芳香族基質のヒドロキシ化法 Active JP7142813B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201619344 2016-11-15
GB1619344.3 2016-11-15
PCT/GB2017/053432 WO2018091885A1 (en) 2016-11-15 2017-11-15 Hydroxylation of branched aliphatic or aromatic substrates employing the amycolatopsis lurida cytochrome p450

Publications (3)

Publication Number Publication Date
JP2019536479A JP2019536479A (ja) 2019-12-19
JP2019536479A5 JP2019536479A5 (enExample) 2020-12-24
JP7142813B2 true JP7142813B2 (ja) 2022-09-28

Family

ID=60421812

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019547195A Active JP7142813B2 (ja) 2016-11-15 2017-11-15 アミコラトプシス・ルリダ由来シトクロムp450を用いた分岐状脂肪族または芳香族基質のヒドロキシ化法

Country Status (4)

Country Link
US (1) US11384371B2 (enExample)
EP (1) EP3541949A1 (enExample)
JP (1) JP7142813B2 (enExample)
WO (1) WO2018091885A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201807815D0 (en) * 2018-05-14 2018-06-27 Hypha Discovery Ltd Hydroxylation techniques
GB201819209D0 (en) 2018-11-26 2019-01-09 Hypha Discovery Ltd Biocatalytic techniques
GB201917077D0 (en) 2019-11-22 2020-01-08 Hypha Discovery Ltd Biocatalytic techniques
CN113072504B (zh) * 2021-03-29 2022-11-22 四川摩尔生物制药有限公司 一种波生坦代谢物的化学合成方法
GB202107512D0 (en) 2021-05-26 2021-07-07 Hypha Discovery Ltd Cytochrome P450 enzyme

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004078978A1 (en) 2003-02-26 2004-09-16 Bristol-Myers Squibb Company Compositions and methods for hydroxylating epothilones
JP2005514031A (ja) 2001-12-26 2005-05-19 ブリストル−マイヤーズ スクイブ カンパニー エポチロンをヒドロキシル化するための組成物および方法
JP2006510386A (ja) 2002-12-17 2006-03-30 ブリストル−マイヤーズ スクイブ カンパニー エポチロンをヒドロキシル化するための方法および組成物
US20140038850A1 (en) 2011-02-11 2014-02-06 University Of Rochester Methods and systems for evaluating and predicting the reactivity of monooxygenase enzymes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011038313A2 (en) 2009-09-25 2011-03-31 Regents Of The University Of Michigan Selective oxidation of c-h bonds of modified substrates by p450 monooxygenase
WO2013073775A1 (en) 2011-11-15 2013-05-23 Industry Foundation Of Chonnam National University Novel method for preparing metabolites of atorvastatin using bacterial cytochrome p450 and composition therefor
GB201807815D0 (en) * 2018-05-14 2018-06-27 Hypha Discovery Ltd Hydroxylation techniques

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005514031A (ja) 2001-12-26 2005-05-19 ブリストル−マイヤーズ スクイブ カンパニー エポチロンをヒドロキシル化するための組成物および方法
JP2006510386A (ja) 2002-12-17 2006-03-30 ブリストル−マイヤーズ スクイブ カンパニー エポチロンをヒドロキシル化するための方法および組成物
WO2004078978A1 (en) 2003-02-26 2004-09-16 Bristol-Myers Squibb Company Compositions and methods for hydroxylating epothilones
US20140038850A1 (en) 2011-02-11 2014-02-06 University Of Rochester Methods and systems for evaluating and predicting the reactivity of monooxygenase enzymes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Definition: cytochrome P450 [Amycolatopsis lurida NRRL 2430].,Database DDBJ/EMBL/GenBank [online],Accession No.KFU83201,2014年09月05日,https://www.ncbi.nlm.nih.gov/protein/KFU83201

Also Published As

Publication number Publication date
JP2019536479A (ja) 2019-12-19
WO2018091885A1 (en) 2018-05-24
EP3541949A1 (en) 2019-09-25
US20190367957A1 (en) 2019-12-05
US11384371B2 (en) 2022-07-12

Similar Documents

Publication Publication Date Title
US11618906B2 (en) Hydroxylation techniques
JP7142813B2 (ja) アミコラトプシス・ルリダ由来シトクロムp450を用いた分岐状脂肪族または芳香族基質のヒドロキシ化法
US6261814B1 (en) Carboxylic acid reductase, and methods of using same
AU2008219996B2 (en) Transformed strains originated from multidrug efflux protein defective strains and a method for microbial conversion using them
US11891642B2 (en) Biocatalytic techniques
Ding et al. Construction of an alternative NAD+ de novo biosynthesis pathway
Xu et al. Highly efficient synthesis of ethyl (S)-4-chloro-3-hydroxybutanoate by a novel carbonyl reductase from Yarrowia lipolytica and using mannitol or sorbitol as cosubstrate
JP4998957B2 (ja) 水酸化酵素遺伝子及びその用途
CN103403174B (zh) 活性药物成分及其中间物的酶促合成
JP7644990B2 (ja) 生体触媒技術
GB2580879A (en) Biocatalytic techniques
US10036047B2 (en) Methods for hydroxylating phenylpropanoids
CN110607335B (zh) 一种烟酰胺腺嘌呤二核苷酸类化合物生物合成方法
GB2581122A (en) Biocatalytic techniques
US20250388875A1 (en) Biocatalytic techniques
US20240263208A1 (en) Cytochrome p450 enzyme
JP4744437B2 (ja) ピコリン酸類の製造方法
Liang et al. Biocatalytic synthesis of chiral five-membered carbasugars intermediates utilizing CV2025 ω-transaminase from Chromobacterium violaceum
RU2395578C2 (ru) Способ продукции (2s,3r,4s)-4-гидрокси-l-изолейцина с использованием бактерии, в которой разрушена активность 4-гидрокси-l-изолейциндегидрогеназы

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190719

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201111

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201111

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210928

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211227

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220308

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220407

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20220506

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220506

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220506

R150 Certificate of patent or registration of utility model

Ref document number: 7142813

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250